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Objective: The purpose of this study was to retrospectively analyze the demographic 
characteristics of patients with central peripheral giant cell granulomas (CGCGs) / 
(PGCGs) an Iranian population. 
Methods: In this 38-year retrospective study, the data were obtained from records of 
1019 patients with CGCG and PGCG of the jaws referred to the Department of Oral 
and Maxillofacial, Pathology, Mashhad University of Medical Sciences, Iran 
between 1972 and 2010. Information regarding age distribution, gender, location of the 
lesion and clinical signs and symptoms was documented. 
Results: A total of 1019 patients were affected by giant cell granuloma lesions 
(GCGLs) including 435 CGCGs and 584 PGCGs. The mean age was 28.91 ± 18.16. 
PGCGs and CGCGs had a peak of occurrence in the first and second decade of life 
respectively. A female predominance was shown in CGCG cases (57.70%), whereas 
PGCGs were more frequent in males (50.85%). Five hundred and ninety eight cases of 
all giant cell lesions (58.7 %) occurred in the mandible. Posterior mandible was the 
most frequent site for both Lesions. The second most common site for PGCG was 
posterior maxilla (21%), whereas anterior mandible was involved in CGCG (19.45%). 
The majority of patients were asymptomatic. Patient's age, location (mandible/maxilla) 
and bleeding were the influential variables on the type of the lesion. 
Conclusion: Although the CGCGs share some histopathologic similarities with 
PGCGs, differences in demographic features may be observed in different populations. 
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Giant cell granuloma lesions (GCGLs) are 
benign, non-odontogenic, relatively 
uncommon tumors of the oral cavity, which 
arise either peripherally within gingiva, or 
centrally as an intraosseous lesion (1). 
The peripheral giant cell granuloma (PGCG) 
is a reactive exophytic lesion arises in 
periodontal ligament and mucoperiosteum of 
the alveolar ridge. It is also known as a 
giant-cell epulis, giant-cell reparative 
granuloma, or giant-cell hyperplasia (2). It 
occurs more frequent in the fifth and sixth 
decades of life with a slight female 
predilection (3).  
The central giant cell granuloma (CGCG) is 
a benign intra-osseous proliferative lesion 
that occurs almost exclusively in the jaws. 
They comprise fewer than 7% of all benign 
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tumors of the jaws (4,5). This lesion mainly 
occurs in children or in young adults, with a 
female predilection. It is more common in 
the mandible (3,6). 
CGCG and PGCG are virtually identical 
histologically, being characterized by the 
presence of osteoclast-like giant cells 
scattered in a cellular fibro-vascular stroma. 
However, despite their similarity, distinct 
clinical behavior is observed for these 
lesions. CGCGs are benign but may show 
aggressive behavior with bone destruction, 
rapid growth, pain, root resorption and 
tendency to recur after excision, whereas 
low recurrence rate and rare bone or tooth 
resorption are seen in PGCGs (7-9). 
There is considerable variation in the 
clinical behavior of CGCG. Rapid onset of 
pain, parasthesia, root resorption, and tooth 
displacement may be seen.  Sometimes these 
lesions are asymptomatic (10). 
The distribution pattern of giant cell 
granulomas (GCGs) observed in one country 
may not be evident in other countries. The 
clinical and demographic features of these 
lesions including patient age and sex, 
location of lesion, and distribution vary with 
race and geographic location. There is no 
extensive data concerning clinico-pathologic 
features of GCGLs in the English-language 
literature in Iranian population. Only 
Motamedi et al. (3) and Aghbali et al. (11) 
studies have been published. 
As GCGs are common lesions in our 
country, we attempted to evaluate 
demographic features of patients in an 
Iranian population. 
The purpose of this study was to 
retrospectively analyze the clinical features 
of 1019 patients with CGCGs and PGCGs in 
Iranian population. The findings were 
compared with the literature in respect of 
age, gender, location of the lesion and 





The data for the retrospective study were 
obtained from records of 1019 patients with 
CGCG and PGCG of the jaws referred to the 
Department of Oral and Maxillofacial, 
Mashhad University of medical Sciences, 
Mashhad, Iran between 1972 and 2010. 
Diagnosis of CGCGs and PGCGS based on 
histological examination of hematoxylin-
and-eosin tissue sections and data in patients 
records (peripheral /central) which was 
reconfirmed by two pathologists.  This 38-
year retrospective study was based on 
existing data. Clinical data were analyzed, 
focusing on age, gender, location of the 
lesions, and clinical signs and symptoms 
including pain, swelling and bleeding which 
were available in patients records. For GCG 
location the following scheme was used. The 
maxilla and mandible were divided into 6 
anatomical regions, 3 on either side: anterior 
(from the midline to the distal surface of the 
canine), posterior (from the mesial aspect of 
the first premolar to the distal side of the 
third molar) and anterior-posterior (12). The 
anatomical region of 46 PGCGs and 60 
CGCGs were not available. Statistical 
analysis was performed using SPSS 
software. For evaluation of influential 
variables on the type of the lesion (PGCG 
and CGCG) binary logistic regression model 
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was performed. The influential variables 
were evaluated in comparing with the 
reference groups including age <10, male 
patient, mandible, existence of swelling and 
bleeding. Data were considered significant 




A total of 1019 out of 9485 patients (10.7%) 
were affected by GCGLs during the study 
(435 CGCGs and 584 PGCGs). Patients 
ranged in age at the time of diagnosis from 2 
to 90 years with a mean age of 28.91 ± 
18.16. PGCGs and CGCGs had a peak of 
occurrence in the first and second decade of 
life respectively. Table 1 shows distribution 
of PGCGs and CGCGs in different decades 
of age with statistically significant 
difference (P<0.05). 
Table1- Relative distribution of PGCGs and 







75(17.24) 118 (20.20) 0-10 
111 (25.51) 97 (16.60) 10-20 
81 (18.62) 90(15.41) 20-30 
64 (14.71) 102 (17.46) 30-40 
51 (11.72) 78 (61) 40-50 
32 (7.35) 63 (13.35) 50-60 
14 (3.21) 17 (2.91) 60-70 
7(1.6) 19(3.25) >70 
435 (100) 584(100) Total 
A female predominance was shown in 
CGCG cases (57.70%), whereas PGCGs 
were more frequent in males (50.85%) with 
statistically significant difference (P<0.05). 
The distribution in terms of gender in 
CGCG and PGCG cases are presented in 
separately Table 2.  
Table2- Relative frequency of giant cell 
granuloma lesions based on sex origin 
287(49.15) Female  
PGCG 
297(50.85) Male  
584(100) Total 
251(57.70) Female  
CGCG 184 (42.30) Male  
435(100) Total 
Five hundred and ninety eight cases of all 
giant cell lesions (58.7 %) occurred in the 
mandible and 421 cases (41.3 %) were in 
maxilla (P<0.05). The mandibular and 
maxillary distribution of PGCGs and 
CGCGs are demonstrated in Table3. 
Table3- Relative frequency of giant cell 
granuloma lesions based on location 
324 (55.5) Mandible  PGCG 
260 (44.5) Maxilla   
584(100) Total  
274 (63) Mandible CGCG 
161 (37) Maxilla   
435 (100) Total  
Posterior mandible was the most frequent 
site for both CGCG (35.75%) and PGCG 
(32.70%) cases. The second most common 
site for PGCG was posterior maxilla (21%), 
whereas anterior mandible was involved in 
CGCG (19.45%). PGCGs were distributed 
equally between the anterior maxilla and 
mandible. Table4 shows the frequency of 
studied lesions based on region of jaws 
without statistically significant differences. 
The majority of patients were asymptomatic. 
Bleeding was reported in 31% of PGCGs 
and 21% of CGCGs (p<0.05). Pain 
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(p=0.626) and swelling (p<0.05) were only 
observed in 6.08 %   and 2.45 % of patients 
respectively. 
Table4- Distribution of anatomical regions for studied lesions in the jaws. 





Posterior  Anterior  Anterior Posterior  Anterior  
538(100) 24 (4.5) 113 (21) 99 (18.40) 28 (5.20) 176 (32.70) 98 (18.20) PGCG 
375(100)_ 22 (5.85) 59 (15.75) 65 (17.35) 22 (5.85) 134(35.75) 73 (19.45) CGCG 
P=0.964 P=0.302 P-value 
 
The influential variables were evaluated in 
comparing with the reference groups. Age 
<10, male patient , mandible, existence of 
swelling as well as of bleeding were 
respectively considered as the reference 
groups for evaluation the influence of  age, 
sex, lesion location (mandible/maxilla), 
swelling and bleeding on the type of the 
lesion (PGCG or CGCG). 
As it is shown in Table 5, the probability of 
allocating female patients to CGCG group is 
1.3 times more than males. The probability 
of allocating maxilla to CGCG group is 0.73 
times more than mandible. 
Moreover, the probability of allocating the 
groups without bleeding and without 
swelling are 1.57 and 0.48 times more than 
groups with bleeding and swelling 
respectively. 
According to the binary logistic regression, 
patient's age, lesion location 
(mandible/maxilla) and bleeding as the 
influential variables showed significant 
effect on the type of the lesion (Table5). 







(95% CIfor OR) 
 
sex .259 .142 .069 1.296 .981 1.712 
jaw -.314 .144 .030 .731 .551 .969 
swelling -.723 .497 .146 .485 .183 1.285 
bleeding .451 .161 .005 1.571 1.146 2.152 
Age   .019    
<10 .570 .217 .008 1.769 1.157 2.704 
10-19 .277 .232 .232 1.320 .837 2.080 
20-29 -.026 .233 .910 .974 .617 1.537 
30-39 .010 .255 .968 1.010 .613 1.664 
40-49 -.194 .287 .500 .824 .469 1.446 
50-59 .335 .462 .468 1.399 .566 3.458 
60-69 -1.042 .664 .117 .353 .096 1.296 
Constant -.088 .543 .871 .916   
1-Standard Error  2-Odds ratio  3-Confidence interval 
Discussion 
 
The present study details the profile of 
patients diagnosed as having central and 
peripheral giant cell granulomas referred to  
the department of oral and maxillofacial, 
Mashhad University of medical Sciences , 
Mashhad, Iran  between 1972 and 2010. A 
total 1019 cases were evaluated, and 
epidemiologic findings were compared with 
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previous studies. It is important to mention 
that we evaluated 1019 lesions in a 38-year 
period, whereas small number of cases 
considered in previous series 
(1,6,9,11,13,14).  
 CGCGs occur more often in patients 
younger than 30 years of age (9,15,16) . In 
our study, a peak of occurrence was in the 
second decade of life, corresponding to the 
findings of other authors (13). Although it 
has been shown that PGCGs occur more 
frequent in the fifth and sixth decades (3) the 
first decade was the most frequent age in the 
current study. In some studies patients were 
aged between four and seven decades, 
whereas most of our patients with PGCG 
were under 40 years old (1). 
It should be noted that in the current study 
influential variables on the type of the lesion 
(PGCG/CGCG) were also evaluated. 
According to the results, patient's age, lesion 
location (mandible/maxilla) and bleeding as 
theinfluential variables showed significant 
effect on the type of the lesion. 
The majority of studies agree that there is a 
female predominance for CGCG lesions 
(3,9,13,15,16) which is in agreement with 
our results. In the present study, PGCGs 
appeared more common in males, which is 
in contrast to the proved thesis that de-
scribes predilection for female patients 
(3,9,13,15-17) . Murat et al (2004) also 
reported male predilection (56%) which was 
slightly higher than our results (18). 
A mandible predominance (58.7%) was 
identified in our series, and is in agreement 
with other studies (4,9,15,18). We also 
reported that only upper jaw effects on the 
type of the lesion including central or 
peripheral giant cell granuloma. 
Similar to our results, previous studies (5, 
10,15,19,20), have been stated that molar 
and premolar areas of mandible were more 
often affected by CGCGs than the anterior 
parts. Most of PGCG cases were also in the 
posterior part of mandible in our study.   The 
second most common site for PGCG was 
posterior maxilla (21%), whereas anterior 
mandible was involved in CGCG (19.45%). 
In contrast to our results Boffano et al 
showed maxilla as the most frequent site for 
PGCGs (20). 
The clinical features of CGCGs varied 
considerably and is hard to predict (9). 
 Bleeding was the most common clinical 
feature in our cases, whereas Sun et al 
reported asymmetric swelling of the jaw as 
the most common clinical aspect in their 
series (11). Swelling was seen in only 3% of 
our cases.  
Pain was considered to be associated with 
aggressive behavior of lesions (16) and was 
the second most frequent clinical aspect in 
our study. It should be mentioned that 
bleeding and pain were more common in 




In conclusion, in contrast to most of 
previous studies PGCGs occur more 
common in the first decade and also more 
frequently in male patients. Although the 
CGCGs share some histopathologic 
similarities with PGCGs, differences in 
demographic features may be observed in 
different populations. Therefore, 
demographic evaluation of lesions which are 
more common in our country may help in 
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